Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,263
in 2 filings

Net −$22,263. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2015-12-15 Doberstein Stephen K SVP & Chief Scientific Officer Grant or award · Stock Option +10,500 10,500
2015-12-04 KUEBLER CHRISTOPHER A Director Exercise or conversion +15,000 $5.15 $77K 35,000
2015-12-04 KUEBLER CHRISTOPHER A Director Sale −15,000 $15.82 $237K 20,000
2015-12-04 KUEBLER CHRISTOPHER A Director Exercise or conversion · Stock Option −15,000 0
2015-12-03 Labrucherie Gil M SVP & General Counsel Exercise or conversion +33,334 $6.98 $233K 38,585
2015-12-03 Labrucherie Gil M SVP & General Counsel Exercise or conversion +11,667 $6.46 $75K 50,252
2015-12-03 Labrucherie Gil M SVP & General Counsel Sale −45,001 $15.87 $714K 5,251
2015-12-03 Labrucherie Gil M SVP & General Counsel Exercise or conversion · Stock Option −33,334 0
2015-12-03 Labrucherie Gil M SVP & General Counsel Exercise or conversion · Stock Option −11,667 23,333
2015-12-03 ROBIN HOWARD W President & CEO Exercise or conversion +58,334 $6.98 $407K 68,334
2015-12-03 ROBIN HOWARD W President & CEO Exercise or conversion +66,667 $6.46 $431K 135,001
2015-12-03 ROBIN HOWARD W President & CEO Sale −125,001 $15.87 $2.0M 10,000
2015-12-03 ROBIN HOWARD W President & CEO Exercise or conversion · Stock Option −58,334 0
2015-12-03 ROBIN HOWARD W President & CEO Exercise or conversion · Stock Option −66,667 133,333
2015-12-03 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion +15,000 $6.65 $100K 18,999
2015-12-03 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −15,000 $15.87 $238K 3,999
2015-12-03 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion · Stock Option −15,000 45,000
2015-11-20 WANG SUSAN Director Exercise or conversion +9,500 $5.14 $49K 29,500
2015-11-20 WANG SUSAN Director Sale −9,500 $15.02 $143K 20,000
2015-11-20 WANG SUSAN Director Exercise or conversion +40,000 $9.24 $370K 60,000

Page 57 of 69 · 1,361 trades